智通财经APP讯，心玮医疗-B(06609)公布，2025年9月29日耗资约61.76万港元回购9700股股份。 ...

格隆汇9月29日丨心玮医疗-B(06609.HK)公告，9月29日耗资61.7万港元回购9700股。 ...

第 1 頁 共 7 頁 v 1.3.0 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海心瑋醫療科技股份有限公司 (於中華人民共和國註冊成立的有限責任公司) 呈交日期： 2025年9月29日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06609 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | ...

Summary of Key Points Core Viewpoint - On September 26, 32 Hong Kong-listed companies conducted share buybacks, totaling 18.93 million shares and an aggregate amount of HKD 787 million [1][2]. Group 1: Buyback Details - Tencent Holdings repurchased 850,000 shares for HKD 550 million, with a highest price of HKD 652.50 and a lowest price of HKD 640.00, bringing its total buyback amount for the year to HKD 56.56 billion [1][2]. - Anta Sports repurchased 1.09 million shares for HKD 99.87 million, with a highest price of HKD 92.55 and a lowest price of HKD 90.20, totaling HKD 1.48 billion in buybacks for the year [1][2]. - Hang Seng Bank repurchased 200,000 shares for HKD 23.32 million, with a highest price of HKD 122.80 and a lowest price of HKD 113.60, accumulating HKD 933.51 million in buybacks for the year [1][2]. Group 2: Buyback Volume Leaders - China Petroleum & Chemical Corporation led in buyback volume with 4.53 million shares repurchased on the same day [1][2]. - Other notable companies in terms of buyback volume included Linklogis Technology and Sihuan Pharmaceutical, with 2.23 million and 1.50 million shares repurchased, respectively [1][2]. Group 3: Additional Buyback Information - The buyback activity on September 26 highlighted a significant trend among Hong Kong-listed companies, with Tencent and Anta leading in terms of monetary value [1][2]. - Medical technology company Yidu Tech was noted for its first buyback of the year, indicating a potential shift in its financial strategy [2].

Core Viewpoint - The Ministry of Industry and Information Technology, along with other governmental bodies, has announced the application process for the 2025 high-end medical equipment promotion project, aiming to enhance innovation and application in the medical equipment sector [1] Industry Summary - The overall revenue of the mainland medical device industry decreased by 3.8% year-on-year in the first half of 2025, with net profit attributable to shareholders dropping by 12.8% [2] - In the second quarter, revenue fell by 5.5% year-on-year, and net profit attributable to shareholders decreased by 20.3% [2] - Approximately 53% of the 129 listed medical device companies reported revenue growth year-on-year, with 16% experiencing growth rates exceeding 20% [1][2] Company Highlights - MicroPort Robotics (02252) reported 16 overseas installations and over 30 new orders in the first half of the year, with overseas revenue accounting for 58% of total revenue [3] - EagleEye Technology (02251) is focusing on AI medical devices and has invested significantly in AGI-related technology, with R&D expenses of 112 million yuan in 2023 [3] - Xinwei Medical (06609) achieved a net profit of 50.94 million yuan in the first half of the year, marking its entry into a profitable phase, and is set to begin clinical trials for its brain-machine interface by the end of next year [4]

自9月24日以来公司已连续3日进行回购，合计回购17.17万股，累计回购金额1069.23万港元。 其间该股 累计上涨9.00%。（数据宝） 心玮医疗-B回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.09.26 | 8.20 | 63.400 | 62.400 | 517.64 | | 2025.09.25 | 5.98 | 63.150 | 60.900 | 370.59 | | 2025.09.24 | 3.00 | 62.450 | 57.400 | 181.00 | （文章来源：证券时报网） 证券时报·数据宝统计，心玮医疗-B在港交所公告显示，9月26日以每股62.400港元至63.400港元的价格 回购8.20万股，回购金额达517.64万港元。该股当日收盘价63.600港元，上涨0.71%，全天成交额 1121.35万港元。 ...

（原标题：心玮医疗-B(06609)9月26日斥资517.64万港元回购8.2万股） 智通财经APP讯，心玮医疗-B(06609)发布公告，于2025年9月26日斥资517.64万港元回购8.2万股股份。 ...

心玮医疗-B(06609)发布公告，于2025年9月26日斥资517.64万港元回购8.2万股股份。 ...

格隆汇9月26日丨心玮医疗-B(06609.HK)公告，9月26日耗资517.6万港元回购8万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海心瑋醫療科技股份有限公司 (於中華人民共和國註冊成立的有限責任公司) 呈交日期： 2025年9月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 06609 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | 事件 | ...